Abiraterone (Zytiga) and Ketamine Therapy | Tovani Health
Zytiga (Abiraterone) (also: Yonsa) — CYP17 inhibitor (metastatic prostate cancer)
Verdict at Tovani Health
Fully compatible with KAP.
Abiraterone and ketamine have no clinically significant interaction. Used for metastatic castration-resistant and castration-sensitive prostate cancer, always co-administered with prednisone (5-10mg) to prevent mineralocorticoid excess. The intrinsic considerations — hypokalemia, fluid retention, hypertension, hepatotoxicity monitoring, and the mandatory glucocorticoid co-administration — are abiraterone-class concerns independent of KAP.
If you take Zytiga regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Zytiga interacts with ketamine
Abiraterone inhibits CYP17A1, blocking androgen synthesis in the testes, adrenals, and tumor tissue. It's a CYP2D6 inhibitor and CYP1A2 inducer, but neither pathway substantially affects ketamine (which is primarily CYP3A4/CYP2B6).
What we do at intake
Continue as prescribed including your prednisone. Disclose your current BP and electrolytes status.
Bottom line
Abiraterone and ketamine have no clinically significant interaction. Used for metastatic castration-resistant and castration-sensitive prostate cancer, always co-administered with prednisone (5-10mg) to prevent mineralocorticoid excess. The intrinsic considerations — hypokalemia, fluid retention, hypertension, hepatotoxicity monitoring, and the mandatory glucocorticoid co-administration — are abiraterone-class concerns independent of KAP.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Zytiga (Abiraterone) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 22, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.